A detailed history of Royce & Associates LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 393,286 shares of CDNA stock, worth $8.11 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
393,286
Previous 392,286 0.25%
Holding current value
$8.11 Million
Previous $6.09 Million 101.54%
% of portfolio
0.12%
Previous 0.06%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$14.41 - $33.99 $14,410 - $33,990
1,000 Added 0.25%
393,286 $12.3 Million
Q2 2024

Aug 13, 2024

SELL
$7.56 - $16.15 $1.1 Million - $2.36 Million
-146,012 Reduced 27.12%
392,286 $6.09 Million
Q1 2024

May 13, 2024

BUY
$7.96 - $12.37 $1.55 Million - $2.41 Million
194,593 Added 56.62%
538,298 $5.7 Million
Q4 2023

Feb 12, 2024

SELL
$4.9 - $12.86 $3.52 Million - $9.23 Million
-717,850 Reduced 67.62%
343,705 $4.12 Million
Q3 2023

Nov 09, 2023

BUY
$7.0 - $11.26 $1.9 Million - $3.05 Million
270,950 Added 34.27%
1,061,555 $7.43 Million
Q2 2023

Aug 07, 2023

BUY
$7.61 - $9.46 $2.73 Million - $3.39 Million
358,100 Added 82.8%
790,605 $6.72 Million
Q1 2023

May 04, 2023

BUY
$8.83 - $17.61 $2.94 Million - $5.85 Million
332,400 Added 332.05%
432,505 $3.95 Million
Q4 2022

May 23, 2023

SELL
$10.88 - $20.05 $3.62 Million - $6.66 Million
-332,400 Reduced 76.85%
100,105 $1.14 Million
Q4 2022

Feb 13, 2023

SELL
$10.88 - $20.05 $728,960 - $1.34 Million
-67,000 Reduced 40.09%
100,105 $1.14 Million
Q3 2022

Nov 03, 2022

SELL
$16.06 - $26.39 $781,318 - $1.28 Million
-48,650 Reduced 22.55%
167,105 $2.84 Million
Q2 2022

Aug 04, 2022

SELL
$20.49 - $39.72 $1.36 Million - $2.63 Million
-66,300 Reduced 23.51%
215,755 $4.63 Million
Q1 2022

May 05, 2022

BUY
$28.19 - $46.6 $140,950 - $233,000
5,000 Added 1.8%
282,055 $10.4 Million
Q4 2021

Feb 07, 2022

BUY
$41.2 - $73.6 $2.16 Million - $3.87 Million
52,535 Added 23.4%
277,055 $12.6 Million
Q3 2021

Nov 10, 2021

SELL
$59.15 - $91.99 $5.48 Million - $8.52 Million
-92,600 Reduced 29.2%
224,520 $14.2 Million
Q2 2021

Aug 06, 2021

BUY
$63.02 - $95.11 $2.36 Million - $3.57 Million
37,500 Added 13.41%
317,120 $29 Million
Q1 2021

May 10, 2021

SELL
$57.62 - $95.6 $10.1 Million - $16.8 Million
-175,779 Reduced 38.6%
279,620 $19 Million
Q4 2020

Feb 08, 2021

SELL
$41.43 - $77.09 $459,002 - $854,080
-11,079 Reduced 2.38%
455,399 $33 Million
Q3 2020

Nov 12, 2020

SELL
$30.88 - $37.94 $2.71 Million - $3.33 Million
-87,900 Reduced 15.86%
466,478 $17.7 Million
Q2 2020

Aug 07, 2020

SELL
$18.95 - $35.43 $482,883 - $902,827
-25,482 Reduced 4.39%
554,378 $19.6 Million
Q1 2020

May 12, 2020

BUY
$13.94 - $28.25 $492,054 - $997,168
35,298 Added 6.48%
579,860 $12.7 Million
Q4 2019

Feb 06, 2020

BUY
$19.24 - $28.41 $4.18 Million - $6.17 Million
217,138 Added 66.32%
544,562 $11.7 Million
Q3 2019

Nov 13, 2019

BUY
$20.03 - $40.08 $3.75 Million - $7.5 Million
187,112 Added 133.35%
327,424 $7.4 Million
Q2 2019

Aug 12, 2019

SELL
$25.78 - $39.77 $2.57 Million - $3.97 Million
-99,800 Reduced 41.56%
140,312 $5.05 Million
Q1 2019

May 09, 2019

SELL
$22.09 - $39.21 $2.99 Million - $5.31 Million
-135,400 Reduced 36.06%
240,112 $7.57 Million
Q4 2018

Feb 11, 2019

SELL
$19.89 - $30.02 $3.85 Million - $5.81 Million
-193,610 Reduced 34.02%
375,512 $9.44 Million
Q3 2018

Nov 13, 2018

SELL
$12.1 - $28.85 $3.6 Million - $8.58 Million
-297,261 Reduced 34.31%
569,122 $16.4 Million
Q2 2018

Aug 09, 2018

SELL
$7.93 - $15.79 $1.09 Million - $2.17 Million
-137,204 Reduced 13.67%
866,383 $10.6 Million
Q1 2018

May 14, 2018

BUY
$5.18 - $7.97 $157,990 - $243,085
30,500 Added 3.13%
1,003,587 $8 Million
Q4 2017

Feb 09, 2018

BUY
$3.98 - $7.37 $717,594 - $1.33 Million
180,300 Added 22.74%
973,087 $7.14 Million
Q3 2017

Nov 13, 2017

BUY
$1.33 - $4.12 $79,135 - $245,140
59,500 Added 8.11%
792,787 $2.93 Million
Q2 2017

Aug 07, 2017

BUY
N/A
733,287
733,287 $814,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.1B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.